Abcellera BiologicsÂ Inc (ABCL) Financials

$10.89

$0.43 (4.11%)

As on 11-Sep-2026 16:20EDT

Market cap

$3,704 Mln

Revenue (TTM)

$66 Mln

P/E Ratio

--

P/B Ratio

4.1

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-131.30	-108.56	-43.88	277.36	244.58
Cash Flow from Investing Activities	--	87.75	121.41	-221.11	-352.63	-332.25
Cash from Financing Activities	--	14.08	12.77	10.36	-1.63	-3.89
Net Cash Inflow / Outflow	--	--	--	--	-76.89	-91.55

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.54	-0.49	-0.55	-0.50	0.53	-0.01
Cash EPS ($)	--	-0.39	-0.22	-0.40	0.64	0.05
Adjusted Book Value ($)	--	3.24	3.58	3.96	4.09	3.26
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.44	-0.37	-0.15	0.92	0.78
Free Cash Flow per Share ($)	--	-0.58	-0.63	-0.42	0.68	0.59

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-13.12	-13.85	-11.50	13.31	-0.23
ROE (%)	-17.68	-14.47	-14.75	-12.27	14.03	-0.24
ROA (%)	-11.64	-10.78	-11.43	-9.67	11.09	-0.19
EBIT Margin (%)	-304.58	-236.39	-1,044.45	-586.59	46.78	-17.24
Net Margin (%)	-248.83	-194.88	-564.83	-385.00	31.20	-8.39
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	101.28	1.61	-0.24	-0.92	40.81	-0.95
EBIT Growth (%)	23.59	41.03	-35.01	-198.23	11,444.74	-101.22
Net Profit Growth (%)	0.61	10.10	-11.24	-192.35	7,270.55	-101.86
EPS Growth (%)	2.53	0.11	-0.10	-1.96	75.94	-1.02
Book Value Growth (%)	-13.08	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-6.98	-5.30	-11.35	19.25	-2,036.87
Price / Book Value	4.11	1.06	0.82	1.44	2.47	4.39
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	3.33	-4.24	-1.48	-5.09	8.64	-24,706.93
Close Price ($)	7.85	3.42	2.93	5.71	10.13	14.30
High Price ($)	8.42	6.52	6.05	11.38	14.97	55.22
Low Price ($)	2.75	1.89	2.34	3.87	5.42	12.20
Market Cap ($ Cr)	3,703.86	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.15	0.06	0.07	0.07	0.04
Short term debt to equity ratio	0.01	0.01	0.00	0.01	0.00	0.00
Current Ratio	12.77	11.32	9.81	7.33	8.67	7.70
Quick Ratio	12.63	11.23	9.81	7.32	8.65	7.69
Interest Coverage	-11.19	--	--	--	56.13	-9.57

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	144.21	204.18	319.53	169.31	21.30	1,505.90
Asset Turnover	0.05	0.06	0.02	0.03	0.34	0.01
Receivable days	--	596.85	991.33	805.86	104.69	6,111.64
Inventory Days	--	40.15	2.08	15.60	8.81	12.36
Payable days	--	377.52	112.70	238.45	81.78	89.25
Cash Conversion Cycle	--	259.48	880.71	583.02	31.71	6,034.74

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.